TMC Life Sciences Bhd Net Assets

Latest as of May 2026: RM867.18 Million MYR ≈ $217.72 Million USD

TMC Life Sciences Bhd net assets. Based on the latest financial reports, TMC Life Sciences Bhd (0101) has net assets worth RM867.18 Million MYR (≈ $217.72 Million USD) as of May 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (RM1.12 Billion ≈ $279.95 Million USD) and total liabilities (RM247.86 Million ≈ $62.23 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore 0101 shareholders equity momentum to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	RM867.18 Million
% of Total Assets	77.77%
Annual Growth Rate	15.45%
5-Year Change	4.81%
10-Year Change	21.38%
Growth Volatility	41.02

Net Assets of TMC Life Sciences Bhd (2006–2026)

Net assets of TMC Life Sciences Bhd from 2006 to 2026. This chart illustrates how TMC Life Sciences Bhd's net assets have evolved over time, based on quarterly financial data. See 0101 net asset quality score to measure how much of total assets are equity-financed.

Annual Net Assets for TMC Life Sciences Bhd (2006–2026)

The table below shows the annual net assets of TMC Life Sciences Bhd from 2006 to 2026. For live market cap and overall valuation, see market cap of TMC Life Sciences Bhd.

Year	Net Assets	Change
2026-08-31	RM867.18 Million ≈ $217.72 Million	+1.66%
2025-08-31	RM853.04 Million ≈ $214.17 Million	-3.94%
2024-08-31	RM888.03 Million ≈ $222.96 Million	+3.03%
2023-08-31	RM861.96 Million ≈ $216.41 Million	+4.18%
2022-08-31	RM827.39 Million ≈ $207.73 Million	+4.78%
2021-08-31	RM789.62 Million ≈ $198.25 Million	+2.27%
2020-08-31	RM772.12 Million ≈ $193.85 Million	+1.30%
2019-08-31	RM762.24 Million ≈ $191.37 Million	+2.97%
2018-08-31	RM740.24 Million ≈ $185.85 Million	+3.61%
2017-08-31	RM714.42 Million ≈ $179.37 Million	+12.64%
2016-08-31	RM634.26 Million ≈ $159.24 Million	+110.22%
2015-08-31	RM301.71 Million ≈ $75.75 Million	+122.84%
2014-08-31	RM135.39 Million ≈ $33.99 Million	+3.11%
2013-08-31	RM131.31 Million ≈ $32.97 Million	+9.25%
2012-08-31	RM120.19 Million ≈ $30.18 Million	+81.99%
2011-08-31	RM66.04 Million ≈ $16.58 Million	-36.21%
2009-08-31	RM103.54 Million ≈ $25.99 Million	-9.19%
2008-08-31	RM114.02 Million ≈ $28.63 Million	+51.35%
2007-08-31	RM75.33 Million ≈ $18.91 Million	+53.85%
2006-08-31	RM48.97 Million ≈ $12.29 Million	--

Equity Component Analysis

This analysis shows how different components contribute to TMC Life Sciences Bhd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 1006.0% over the analyzed period, indicating profitable operations and earnings retention.

TMC Life Sciences Bhd Net Assets Breakdown (August 2026)

TMC Life Sciences Bhd net assets breakdown by equity component as of August 2026.

Component	Amount	Percentage
Retained Earnings	RM241.19 Million	27.81%
Common Stock	RM625.99 Million	72.19%
Total Equity	RM867.18 Million	100.00%

TMC Life Sciences Bhd Competitors by Market Cap

The table below lists competitors of TMC Life Sciences Bhd ranked by their market capitalization.

Company	Market Cap
Wah Hong Industrial TWO:8240	$183.69 Million
Kao Hsiung Chang Iron & Steel Corp TW:2008	$183.69 Million
Galan Lithium Limited F:9CH	$183.72 Million
Baticim Bati Anadolu Cimento Sanayi AS IS:BTCIM	$183.72 Million
Jikai Equipment Manufacturing Co Ltd SHE:002691	$183.59 Million
Malayan Flour Mills Bhd KLSE:3662	$183.56 Million
Solarius Capital Acquisition Corp. NASDAQ:SOCA	$183.55 Million
Mobiltel Iletisim Hizmetleri Sanayi ve Ticaret AS IS:MOBTL	$183.43 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in TMC Life Sciences Bhd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2025 to 2026, total equity changed from 853,043,000 to 867,178,000, a change of 14,135,000 (1.7%).
Net income of 17,380,000 contributed positively to equity growth.
Dividend payments of 3,245,000 reduced retained earnings.

Equity Change Factors (2025 to 2026)

Factor	Impact	Contribution
Net Income	RM17.38 Million	+2.0%
Dividends Paid	RM3.25 Million	-0.37%
Total Change	RM-	1.66%

Book Value vs Market Value Analysis

This analysis compares TMC Life Sciences Bhd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.84x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 1.57x to 0.84x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2006-08-31	RM0.27	RM0.42	x
2007-08-31	RM0.40	RM0.42	x
2008-08-31	RM0.20	RM0.42	x
2009-08-31	RM0.16	RM0.42	x
2011-08-31	RM0.11	RM0.42	x
2012-08-31	RM0.14	RM0.42	x
2013-08-31	RM0.11	RM0.42	x
2014-08-31	RM0.11	RM0.42	x
2015-08-31	RM0.31	RM0.42	x
2016-08-31	RM0.34	RM0.42	x
2017-08-31	RM0.38	RM0.42	x
2018-08-31	RM0.41	RM0.42	x
2019-08-31	RM0.44	RM0.42	x
2020-08-31	RM0.44	RM0.42	x
2021-08-31	RM0.45	RM0.42	x
2022-08-31	RM0.47	RM0.42	x
2023-08-31	RM0.49	RM0.42	x
2024-08-31	RM0.51	RM0.42	x
2025-08-31	RM0.49	RM0.42	x
2026-08-31	RM0.50	RM0.42	x

Capital Efficiency Dashboard

This dashboard shows how efficiently TMC Life Sciences Bhd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 2.00%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 4.42%
• Asset Turnover: 0.35x
• Equity Multiplier: 1.29x
Recent ROE (2.00%) is above the historical average (0.88%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2006	18.72%	36.81%	0.41x	1.24x	RM4.27 Million
2007	12.38%	29.85%	0.33x	1.25x	RM1.80 Million
2008	3.14%	9.21%	0.23x	1.49x	RM-7.83 Million
2009	-8.51%	-18.65%	0.27x	1.68x	RM-19.15 Million
2011	-53.02%	-43.44%	0.55x	2.21x	RM-41.62 Million
2012	-5.34%	-10.36%	0.40x	1.28x	RM-18.44 Million
2013	8.44%	15.34%	0.46x	1.19x	RM-2.05 Million
2014	4.77%	7.47%	0.53x	1.22x	RM-7.08 Million
2015	3.29%	9.62%	0.30x	1.13x	RM-20.25 Million
2016	2.35%	11.66%	0.18x	1.10x	RM-48.53 Million
2017	3.64%	17.16%	0.20x	1.08x	RM-45.41 Million
2018	3.75%	16.44%	0.21x	1.08x	RM-46.23 Million
2019	2.74%	10.73%	0.23x	1.11x	RM-55.30 Million
2020	2.06%	8.65%	0.19x	1.23x	RM-61.28 Million
2021	2.57%	10.08%	0.19x	1.34x	RM-58.71 Million
2022	5.00%	16.98%	0.22x	1.37x	RM-41.35 Million
2023	4.55%	12.60%	0.26x	1.37x	RM-46.94 Million
2024	4.58%	11.73%	0.29x	1.34x	RM-48.16 Million
2025	0.42%	1.04%	0.31x	1.33x	RM-81.70 Million
2026	2.00%	4.42%	0.35x	1.29x	RM-69.34 Million

Industry Comparison

This section compares TMC Life Sciences Bhd's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

Industry: Medical Care Facilities
Average net assets among peers: $4,735,858,826
Average return on equity (ROE) among peers: 19.26%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
TMC Life Sciences Bhd (0101)	RM867.18 Million	18.72%	0.29x	$183.68 Million
Optimax Holdings Sdn Bhd (0222)	$57.74 Million	21.30%	0.60x	$67.52 Million
Cengild Medical Berhad (0243)	$106.11 Million	12.52%	0.24x	$33.46 Million
DC HEALTHCARE HOLDINGS BERHAD (0283)	$15.05 Million	63.52%	2.21x	$18.76 Million
ALPHA (0303)	$28.36 Million	8.70%	1.64x	$335.40 Million
IHH Healthcare Bhd (5225)	$27.04 Billion	0.74%	0.65x	$17.41 Billion
KPJ Healthcare Bhd (5878)	$1.17 Billion	8.79%	1.42x	$2.93 Billion

About TMC Life Sciences Bhd

KLSE:0101 Malaysia Medical Care Facilities

Market Cap

$183.68 Million

RM731.59 Million MYR

Market Cap Rank

#16669 Global

#224 in Malaysia

Share Price

RM0.42

Change (1 day)

+1.20%

52-Week Range

RM0.41 - RM0.57

All Time High

RM0.96